4Basebio

4Basebio EBITDA per Share

The EBITDA per Share of 4Basebio (4BB.L) as of Oct 17, 2026 is -1.08 GBP. In the previous year, EBITDA per Share was -0.85 GBP — a change of 26.72% (lower).

EBITDA per Share

-1.08GBP

YoY

26.72%

Last updated:

EBITDA per Share of 4Basebio is 2025 -1.08 GBP. EBITDA per Share of 4Basebio was 2024 -0.85 GBP. It decreases by 26.72% lower compared to the previous year.

The 4Basebio EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-0.03 GBP
Jan 1, 2020
-0.04 GBP
Jan 1, 2021
-0.26 GBP
Jan 1, 2022
-0.44 GBP
Jan 1, 2023
-0.60 GBP
Jan 1, 2024
-0.85 GBP
Jan 1, 2025
-1.08 GBP
The 4Basebio EBITDA per Share history
YEAREBITDA per ShareYoY
-1.08GBP+26.72%
-0.85GBP+42.52%
-0.60GBP+35.73%
-0.44GBP+68.19%
-0.26GBP+502.25%
-0.04GBP+45.90%
-0.03GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

4Basebio Stock analysis

What does 4Basebio do? 4Basebio PLC, based in Cambridge, UK, operates in the Health Care sector within the Biotechnology industry. The company develops advanced therapy medicinal products using synthetic DNA and non-viral, cell-targeting nucleic acid delivery platforms. It focuses on therapeutic DNA for cell and gene therapies, DNA vaccines, and provides solutions for safe and effective delivery of these products. 4Basebio manufactures application-specific synthetic DNA for research, therapeutic, and pharmacological use, and develops non-viral vectors for efficient payload delivery. Key applications include AAV and Lentivirus vectors, mRNA vaccines, genome editing, and DNA vaccines. 4Basebio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 4Basebio stock

EBITDA per Share of 4Basebio is -1.08 GBP in 2025.

EBITDA per Share of 4Basebio changed from -0.85 GBP to -1.08 GBP, representing a 26.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share 4Basebio since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — 4Basebio

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — 4Basebio